{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:43:28Z","timestamp":1755801808775,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-13033-z","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T17:44:25Z","timestamp":1755711865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oncological outcome and survival predictors of widowed patients with bladder cancer in special populations"],"prefix":"10.1038","volume":"15","author":[{"given":"Fu-Zhen","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Le","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu-Xiong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"1","key":"13033_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L. et al. Cancer statistics, 2023. CA-CANCER J. CLIN. 73 (1), 17\u201348. https:\/\/doi.org\/10.3322\/caac.21763 (2023).","journal-title":"CA-CANCER J. CLIN."},{"issue":"6","key":"13033_CR2","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta, A. R. et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. LANCET ONCOL. 24 (6), 669\u2013681. https:\/\/doi.org\/10.1016\/S1470-2045(23)00170-5 (2023).","journal-title":"LANCET ONCOL."},{"key":"13033_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16223766","author":"P Russo","year":"2024","unstructured":"Russo, P. et al. Relationship between loss of Y chromosome and urologic cancers: New future perspectives. Cancers (Basel)https:\/\/doi.org\/10.3390\/cancers16223766 (2024).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"13033_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","volume":"18","author":"W Fang","year":"2020","unstructured":"Fang, W. et al. Ethnicity and survival in bladder cancer: A population-based study based on the SEER database. J. Transl. Med.18(1), 145. https:\/\/doi.org\/10.1186\/s12967-020-02308-w (2020).","journal-title":"J. Transl. Med."},{"issue":"38","key":"13033_CR5","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.2217\/fon-2022-0843","volume":"18","author":"S Li","year":"2023","unstructured":"Li, S. et al. Nomogram to predict overall survival in patients with primary bladder neuroendocrine carcinoma: A population-based study. Future Oncol.18(38), 4171\u20134181. https:\/\/doi.org\/10.2217\/fon-2022-0843 (2023).","journal-title":"Future Oncol."},{"issue":"3","key":"13033_CR6","doi-asserted-by":"publisher","first-page":"76e1","DOI":"10.1016\/j.urolonc.2019.10.018","volume":"38","author":"G Rosiello","year":"2019","unstructured":"Rosiello, G. et al. Unmarried men have worse oncologic outcomes after radical cystectomy for nonmetastatic urothelial bladder cancer. UROL. ONCOL-SEMIN ORI. 38 (3), 76e1\u201376e9. https:\/\/doi.org\/10.1016\/j.urolonc.2019.10.018 (2019).","journal-title":"UROL. ONCOL-SEMIN ORI"},{"issue":"29","key":"13033_CR7","doi-asserted-by":"publisher","first-page":"e11378","DOI":"10.1097\/MD.0000000000011378","volume":"97","author":"Q Niu","year":"2018","unstructured":"Niu, Q. et al. The effect of marital status on the survival of patients with bladder urothelial carcinoma: A SEER database analysis. Medicine97(29), e11378. https:\/\/doi.org\/10.1097\/MD.0000000000011378 (2018).","journal-title":"Medicine"},{"issue":"5","key":"13033_CR8","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/j.clgc.2016.04.006","volume":"14","author":"Z Klaassen","year":"2016","unstructured":"Klaassen, Z. et al. Female, black, and unmarried patients are more likely to present with metastatic bladder urothelial carcinoma. CLIN. GENITOURIN. CANC. 14 (5), e489\u2013e492. https:\/\/doi.org\/10.1016\/j.clgc.2016.04.006 (2016).","journal-title":"CLIN. GENITOURIN. CANC"},{"issue":"6","key":"13033_CR9","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1002\/cncr.21295","volume":"104","author":"JL Gore","year":"2005","unstructured":"Gore, J. L. et al. Marriage and mortality in bladder carcinoma. Cancer104(6), 1188\u20131194. https:\/\/doi.org\/10.1002\/cncr.21295 (2005).","journal-title":"Cancer"},{"issue":"10","key":"13033_CR10","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jech.2008.082438","volume":"63","author":"GD Datta","year":"2009","unstructured":"Datta, G. D. et al. Marital status and survival following bladder cancer. J. EPIDEMIOL. COMMUN. H. 63 (10), 807\u2013813. https:\/\/doi.org\/10.1136\/jech.2008.082438 (2009).","journal-title":"J. EPIDEMIOL. COMMUN. H"},{"issue":"3","key":"13033_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.urolonc.2008.04.016","volume":"27","author":"JL Nelles","year":"2008","unstructured":"Nelles, J. L., Joseph, S. A. & Konety, B. R. The impact of marriage on bladder cancer mortality. UROL. ONCOL-SEMIN ORI. 27 (3), 263\u2013267. https:\/\/doi.org\/10.1016\/j.urolonc.2008.04.016 (2008).","journal-title":"UROL. ONCOL-SEMIN ORI"},{"key":"13033_CR12","unstructured":"Hankey, B. F., Ries, L. A. & Edwards, B. K. The surveillance, epidemiology, and end results program: a national resource. CANCER EPIDEM BIOMAR. ; 8 (12): 1117-21. PMID: 10613347. (1999)."},{"key":"13033_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.breast.2019.05.015","volume":"47","author":"X Pan","year":"2019","unstructured":"Pan, X. et al. Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study. BREAST 47, 56\u201361. https:\/\/doi.org\/10.1016\/j.breast.2019.05.015 (2019).","journal-title":"BREAST"},{"key":"13033_CR14","doi-asserted-by":"publisher","first-page":"825598","DOI":"10.3389\/fonc.2022.825598","volume":"12","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Based on the development and verification of a risk stratification nomogram: Predicting the risk of lung cancer-specific mortality in stage IIIA-N2 unresectable large cell lung neuroendocrine cancer compared with lung squamous cell cancer and lung adenocarcinoma. Front. Oncol.12, 825598. https:\/\/doi.org\/10.3389\/fonc.2022.825598 (2022).","journal-title":"Front. Oncol."},{"issue":"22","key":"13033_CR15","doi-asserted-by":"publisher","first-page":"641","DOI":"10.21037\/atm.2019.10.77","volume":"7","author":"C Yu","year":"2019","unstructured":"Yu, C. & Zhang, Y. Development and validation of prognostic nomogram for young patients with gastric cancer. Ann. Transl. Med.7(22), 641. https:\/\/doi.org\/10.21037\/atm.2019.10.77 (2019).","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"13033_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00970-y","volume":"28","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. A model for predicting overall survival in bladder cancer patients with signet ring cell carcinoma: A population-based study. Eur. J. Med. Res.28(1), 61. https:\/\/doi.org\/10.1186\/s40001-022-00970-y (2023).","journal-title":"Eur. J. Med. Res."},{"key":"13033_CR17","doi-asserted-by":"publisher","first-page":"107327482311523","DOI":"10.1177\/10732748231152322","volume":"30","author":"W Lin","year":"2023","unstructured":"Lin, W. et al. Impact of age at diagnosis of bladder cancer on survival: A surveillance, epidemiology, and end results-based study 2004\u20132015. Cancer Control30, 10732748231152322. https:\/\/doi.org\/10.1177\/10732748231152322 (2023).","journal-title":"Cancer Control"},{"issue":"1","key":"13033_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12894-020-00769-1","volume":"20","author":"M Amiri","year":"2020","unstructured":"Amiri, M. et al. Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013\u20132018): A population-based study. BMC Urol.20(1), 195. https:\/\/doi.org\/10.1186\/s12894-020-00769-1 (2020).","journal-title":"BMC Urol."},{"issue":"12","key":"13033_CR19","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1097\/COC.0000000000000766","volume":"43","author":"S Luzzago","year":"2020","unstructured":"Luzzago, S. et al. Effect of age on Cancer-specific mortality in patients with urothelial carcinoma of the urinary bladder: A Population-based Competing-risks analysis across disease stages. AM. J. CLIN. ONCOL-CANC. 43 (12), 880\u2013888. https:\/\/doi.org\/10.1097\/COC.0000000000000766 (2020).","journal-title":"AM. J. CLIN. ONCOL-CANC"},{"issue":"3","key":"13033_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.eururo.2015.06.042","volume":"70","author":"MG Cumberbatch","year":"2015","unstructured":"Cumberbatch, M. G. et al. The role of tobacco smoke in bladder and kidney carcinogenesis: A comparison of exposures and Meta-analysis of incidence and mortality risks. EUR. UROL. 70 (3), 458\u2013466. https:\/\/doi.org\/10.1016\/j.eururo.2015.06.042 (2015).","journal-title":"EUR. UROL."},{"issue":"17","key":"13033_CR21","doi-asserted-by":"publisher","first-page":"6857","DOI":"10.1158\/0008-5472.CAN-09-1091","volume":"69","author":"MC Stern","year":"2009","unstructured":"Stern, M. C. et al. Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer. CANCER RES. 69 (17), 6857\u20136864. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1091 (2009).","journal-title":"CANCER RES."},{"issue":"6","key":"13033_CR22","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.eururo.2020.09.006","volume":"78","author":"JY Teoh","year":"2020","unstructured":"Teoh, J. Y. et al. Global trends of bladder cancer incidence and mortality, and their associations with tobacco use and gross domestic product per capita. EUR. UROL. 78 (6), 893\u2013906. https:\/\/doi.org\/10.1016\/j.eururo.2020.09.006 (2020).","journal-title":"EUR. UROL."},{"issue":"7","key":"13033_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jama.2011.1142","volume":"306","author":"ND Freedman","year":"2011","unstructured":"Freedman, N. D. Association between smoking and risk of bladder cancer among men and women. JAMA306(7), 737\u2013745. https:\/\/doi.org\/10.1001\/jama.2011.1142 (2011).","journal-title":"JAMA"},{"issue":"7","key":"13033_CR24","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1158\/1055-9965.EPI-06-0021","volume":"15","author":"C Samanic","year":"2006","unstructured":"Samanic, C. et al. Smoking and bladder cancer in spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. CANCER EPIDEM BIOMAR. 15 (7), 1348\u20131354. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0021 (2006).","journal-title":"CANCER EPIDEM BIOMAR"},{"key":"13033_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.arr.2017.03.008","volume":"36","author":"C Jackaman","year":"2017","unstructured":"Jackaman, C. et al. Aging and cancer: the role of macrophages and neutrophils. AGEING RES. REV. 36, 105\u2013116. https:\/\/doi.org\/10.1016\/j.arr.2017.03.008 (2017).","journal-title":"AGEING RES. REV."},{"key":"13033_CR26","doi-asserted-by":"publisher","unstructured":"Campisi, J. & Yaswen, P. Aging and cancer cell biology, AGING CELL. 2009; 8 (3): 221-5. (2009). https:\/\/doi.org\/10.1111\/j.1474-9726.2009.00475.x","DOI":"10.1111\/j.1474-9726.2009.00475.x"},{"issue":"6","key":"13033_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1158\/2159-8290.CD-16-0062","volume":"6","author":"JW Shay","year":"2016","unstructured":"Shay, J. W. Role of telomeres and telomerase in aging and cancer. CANCER DISCOV. 6 (6), 584\u2013593. https:\/\/doi.org\/10.1158\/2159-8290.CD-16-0062 (2016).","journal-title":"CANCER DISCOV"},{"issue":"6","key":"13033_CR28","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jamcollsurg.2006.08.026","volume":"203","author":"FE Turrentine","year":"2006","unstructured":"Turrentine, F. E. et al. Surgical risk factors, morbidity, and mortality in elderly patients. J. AM. COLL. Surg. 203 (6), 865\u2013877. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2006.08.026 (2006).","journal-title":"J. AM. COLL. Surg."},{"issue":"1","key":"13033_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-016-0329-8","volume":"16","author":"HS Lin","year":"2016","unstructured":"Lin, H. S. et al. Frailty and post-operative outcomes in older surgical patients: A systematic review. BMC Geriatr.16(1), 157. https:\/\/doi.org\/10.1186\/s12877-016-0329-8 (2016).","journal-title":"BMC Geriatr."},{"key":"13033_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071270","author":"F Gavi","year":"2024","unstructured":"Gavi, F. et al. Assessing trifecta and pentafecta success rates between robot-assisted vs. open radical cystectomy: A propensity score-matched analysis. Cancers (Basel)https:\/\/doi.org\/10.3390\/cancers16071270 (2024).","journal-title":"Cancers (Basel)"},{"issue":"12","key":"13033_CR31","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/iju.15586","volume":"31","author":"G Palermo","year":"2024","unstructured":"Palermo, G. et al. The mental and emotional status after radical cystectomy and different urinary diversion orthotopic bladder substitution versus external urinary diversion after radical cystectomy: A propensity score-matched study. INT. J. UROL. 31 (12), 1423\u20131428. https:\/\/doi.org\/10.1111\/iju.15586 (2024).","journal-title":"INT. J. UROL."},{"issue":"14","key":"13033_CR32","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1200\/JCO.2007.10.6583","volume":"25","author":"SM Lichtman","year":"2007","unstructured":"Lichtman, S. M. et al. International society of geriatric oncology chemotherapy taskforce: evaluation of chemotherapy in older patients\u2013an analysis of the medical literature. J. CLIN. ONCOL. 25 (14), 1832\u20131843. https:\/\/doi.org\/10.1200\/JCO.2007.10.6583 (2007).","journal-title":"J. CLIN. ONCOL."},{"issue":"15","key":"13033_CR33","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/cncr.34255","volume":"128","author":"A Martini","year":"2022","unstructured":"Martini, A. et al. Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring. Cancer128(15), 2892\u20132897. https:\/\/doi.org\/10.1002\/cncr.34255 (2022).","journal-title":"Cancer"},{"issue":"10","key":"13033_CR34","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.urolonc.2018.07.012","volume":"36","author":"P Gild","year":"2018","unstructured":"Gild, P. et al. Racial disparity in quality of care and overall survival among black vs. white patients with muscle-invasive bladder cancer treated with radical cystectomy: A National cancer database analysis. UROL. ONCOL-SEMIN ORI. 36 (10), 469. https:\/\/doi.org\/10.1016\/j.urolonc.2018.07.012 (2018).","journal-title":"UROL. ONCOL-SEMIN ORI"},{"issue":"2","key":"13033_CR35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3233\/BLC-150041","volume":"2","author":"DR Kaye","year":"2016","unstructured":"Kaye, D. R. et al. Do African American patients treated with radical cystectomy for bladder cancer have worse overall survival?? Accounting for pathologic staging and patient demographics beyond race makes a difference. Bladder Cancer2(2), 225\u2013234. https:\/\/doi.org\/10.3233\/BLC-150041 (2016).","journal-title":"Bladder Cancer"},{"issue":"7","key":"13033_CR36","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10552-017-0902-2","volume":"28","author":"SB Williams","year":"2017","unstructured":"Williams, S. B. et al. Population-based assessment of racial\/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. CANCER CAUSE CONTROL. 28 (7), 755\u2013766. https:\/\/doi.org\/10.1007\/s10552-017-0902-2 (2017).","journal-title":"CANCER CAUSE CONTROL"},{"issue":"1","key":"13033_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/cncr.24701","volume":"116","author":"BK Hollenbeck","year":"2010","unstructured":"Hollenbeck, B. K. et al. Racial differences in treatment and outcomes among patients with early stage bladder cancer. Cancer116(1), 50\u201356. https:\/\/doi.org\/10.1002\/cncr.24701 (2010).","journal-title":"Cancer"},{"issue":"1","key":"13033_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s40615-014-0055-x","volume":"2","author":"C DeDeugd","year":"2014","unstructured":"DeDeugd, C. et al. The influence of race on overall survival in patients with newly diagnosed bladder cancer. J. RACIAL ETHN. HEALTH. 2 (1), 124\u2013131. https:\/\/doi.org\/10.1007\/s40615-014-0055-x (2014).","journal-title":"J. RACIAL ETHN. HEALTH"},{"issue":"10","key":"13033_CR39","first-page":"602","volume":"35","author":"SB Williams","year":"2017","unstructured":"Williams, S. B. et al. Survival differences among patients with bladder cancer according to sex: critical evaluation of radical cystectomy use and delay to treatment. UROL. ONCOL-SEMIN ORI. 35 (10), 602. .e1-602.e9 (2017).","journal-title":"UROL. ONCOL-SEMIN ORI"},{"issue":"1","key":"13033_CR40","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.euf.2015.01.001","volume":"1","author":"RT Bryan","year":"2015","unstructured":"Bryan, R. T. et al. A comparative analysis of the influence of gender, pathway delays, and risk factor exposures on the Long-term outcomes of bladder cancer. Eur. Urol. Focus. 1 (1), 82\u201389. https:\/\/doi.org\/10.1016\/j.euf.2015.01.001 (2015).","journal-title":"Eur. Urol. Focus"},{"issue":"4","key":"13033_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/21681805.2016.1158207","volume":"50","author":"A Thorstenson","year":"2016","unstructured":"Thorstenson, A. et al. Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National registry of urinary bladder cancer. SCAND. J. UROL. 50 (4), 292\u2013297. https:\/\/doi.org\/10.3109\/21681805.2016.1158207 (2016).","journal-title":"SCAND. J. UROL."},{"issue":"17","key":"13033_CR42","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.7150\/jca.21130","volume":"8","author":"R Pichler","year":"2017","unstructured":"Pichler, R. et al. Gender-related outcome in bladder cancer patients undergoing radical cystectomy. J. Cancer.8(17), 3567\u20133574. https:\/\/doi.org\/10.7150\/jca.21130 (2017).","journal-title":"J. Cancer."},{"key":"13033_CR43","doi-asserted-by":"publisher","unstructured":"Liu, L. et al. Effects of different organ metastases on the prognosis of stage IV urothelial carcinoma of the bladder. J. ONCOL. 2022 (8594022). https:\/\/doi.org\/10.1155\/2022\/8594022 (2022).","DOI":"10.1155\/2022\/8594022"},{"issue":"5","key":"13033_CR44","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1097\/JU.0000000000002422","volume":"207","author":"R Mastroianni","year":"2022","unstructured":"Mastroianni, R. et al. Open radical cystectomy versus Robot-Assisted radical cystectomy with intracorporeal urinary diversion: early outcomes of a Single-Center randomized controlled trial. J. Urol. 207 (5), 982\u2013992. https:\/\/doi.org\/10.1097\/JU.0000000000002422 (2022).","journal-title":"J. Urol."},{"issue":"4","key":"13033_CR45","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s00345-019-02842-3","volume":"38","author":"A Brassetti","year":"2019","unstructured":"Brassetti, A. et al. Long-term oncologic outcomes of robot-assisted radical cystectomy (RARC) with totally intracorporeal urinary diversion (ICUD): A multi-center study. World J. Urol.38(4), 837\u2013843. https:\/\/doi.org\/10.1007\/s00345-019-02842-3 (2019).","journal-title":"World J. Urol."},{"issue":"3","key":"13033_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/JCO.1984.2.3.187","volume":"2","author":"CC Schag","year":"1984","unstructured":"Schag, C. C., Heinrich, R. L. & Ganz, P. A. Karnofsky performance status revisited: reliability, validity, and guidelines. J. CLIN. ONCOL. 2 (3), 187\u2013193. https:\/\/doi.org\/10.1200\/JCO.1984.2.3.187 (1984).","journal-title":"J. CLIN. ONCOL."},{"key":"13033_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031133","author":"ML Iacovino","year":"2022","unstructured":"Iacovino, M. L. et al. Novel therapeutic opportunities in neoadjuvant setting in urothelial cancers: A new horizon opened by molecular classification and immune checkpoint inhibitors. Int. J. Mol. Sci.https:\/\/doi.org\/10.3390\/ijms23031133 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"13033_CR48","doi-asserted-by":"publisher","first-page":"102358","DOI":"10.1016\/j.eucr.2023.102358","volume":"47","author":"K Kokura","year":"2023","unstructured":"Kokura, K. et al. A case of avelumab response to multiple bone and lymph node metastases of plasmacytoid variant bladder cancer. Urol. Case Rep. 47, 102358. https:\/\/doi.org\/10.1016\/j.eucr.2023.102358 (2023).","journal-title":"Urol. Case Rep."},{"issue":"10236","key":"13033_CR49","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/S0140-6736(20)30230-0","volume":"395","author":"MD Galsky","year":"2020","unstructured":"Galsky, M. D. et al. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial. LANCET 395 (10236), 1547\u20131557. https:\/\/doi.org\/10.1016\/S0140-6736(20)30230-0 (2020).","journal-title":"LANCET"},{"issue":"3","key":"13033_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.70033","volume":"4","author":"J Hu","year":"2025","unstructured":"Hu, J. et al. Efficacy and biomarker analysis of neoadjuvant disitamab vedotin (RC48-ADC) combined immunotherapy in patients with muscle-invasive bladder cancer: A multi-center real-world study. Imeta4(3), e70033. https:\/\/doi.org\/10.1002\/imt2.70033 (2025).","journal-title":"Imeta"},{"issue":"11","key":"13033_CR51","doi-asserted-by":"publisher","first-page":"100785","DOI":"10.1016\/j.xcrm.2022.100785","volume":"3","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study. Cell. Rep. Med. 3 (11), 100785. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100785 (2022).","journal-title":"Cell. Rep. Med."},{"issue":"7","key":"13033_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1470-2045(21)00152-2","volume":"22","author":"T Powles","year":"2021","unstructured":"Powles, T. et al. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial. LANCET ONCOL. 22 (7), 931\u2013945. https:\/\/doi.org\/10.1016\/S1470-2045(21)00152-2 (2021).","journal-title":"LANCET ONCOL."},{"issue":"1","key":"13033_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01261-w","volume":"28","author":"L Liu","year":"2023","unstructured":"Liu, L. et al. Development and validation a model for predicting overall survival of bladder cancer with lung metastasis: A population-based study. Eur. J. Med. Res.28(1), 279. https:\/\/doi.org\/10.1186\/s40001-023-01261-w (2023).","journal-title":"Eur. J. Med. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13033-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13033-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T17:44:26Z","timestamp":1755711866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13033-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13033"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13033-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The data of this study were obtained from the SEER database. The patients\u2019 data were public and anonymous, so this study does not require ethical approval and informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"30638"}}